**3.6. ARD-209 (ADENOVIR)**

As a result of the studies carried out by G. Wadell, N. Arnberg and others in University of Umea in Sweden (2014–2017), O. Sterner and U. Ellervik (University of Lund, Sweden) synthesized the substance APD-209, announced as ADENOVIR (Pharma). It was noted that this substance with unknown structure for the publicity is considered as a new solution for the treatment of viral eye infections [47].

Other Swedish authors [48] reported also that **analogues of 2-[2-(benzoylamino)benzoyl amino]benzoic acid** possess inhibitory effect on adenovirus replication.
